Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization.
Usama AhmadJuber AkhtarSatya Prakash SinghFarhan Jalees AhmadSahabjada SiddiquiPublished in: Artificial cells, nanomedicine, and biotechnology (2017)
Our results concluded that nanoemulsion may be an efficient carrier for oral delivery of silymarin against human hepatocellular carcinoma without damaging normal cells.